FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer

被引:53
作者
Lin, Lilie L.
Yang, Zhiyun
Mutic, Sasa
Miller, Tom R.
Grigsby, Perry W.
机构
[1] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[3] Mallinckrodt Inst Radiol, Dept Radiol, Div Nucl Med, St Louis, MO 63110 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
关键词
positron emission tomography; cervix; FDG-PET; tumor volume;
D O I
10.1016/j.ijrobp.2005.12.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the physiologic tumor volume response during treatment in cervical cancer using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Patients and Methods: This was a prospective study of 32 patients. Physiologic tumor volume in cubic centimeters was determined from the FDG-PET images using the 40% threshold method. Results: The mean pretreatment tumor volume was 102 cm(3). The mean volume by clinical Stages I, II, and III were 54, 79, and 176 cm(3), respectively. After 19.8 Gy external irradiation to the pelvis, the reduction in tumor was 29% (72 cm(3)). An additional 13 Gy from high-dose-rate (HDR) brachytherapy reduced the mean to 15.4 cm(3), and this was subsequently reduced to 8.6 cm(3) with 13 Gy additional HDR brachytherapy (26 Gy, HDR). Four patients had physiologic FDG uptake in the cervix at 3 months after the completion of therapy. The mean time to the 50% reduction in physiologic tumor volume was 19.9 days and after combined external irradiation and HDR to 24.9 Gy. Conclusion: These results indicate that physiologic tumor volume determination by FDG-PET is feasible and that a 50% physiologic tumor volume reduction occurs within 20 days of starting therapy. (c) 2006 Elsevier Inc.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 50 条
  • [31] FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer
    Shinya Oku
    Keiichi Nakagawa
    Toshimitsu Momose
    Yoshitaka Kumakura
    Atsushi Abe
    Toshiaki Watanabe
    Kuni Ohtomo
    Annals of Nuclear Medicine, 2002, 16
  • [32] The Use of FDG-PET to Target Tumors by Radiotherapy
    Lammering, Guido
    De Ruysscher, Dirk
    van Baardwijk, Angela
    Baumert, Brigitta G.
    Borger, Jacques
    Lutgens, Ludy
    van den Ende, Piet
    Ollers, Michel
    Lambin, Philippe
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (09) : 471 - 481
  • [33] FDG-PET/CT in the surveillance of head and neck cancer following radiotherapy
    Risor, Louise Madeleine
    Loft, Annika
    Berthelsen, Anne Kiil
    Loft, Frederik Cornelius
    Madsen, Andreas Ruhvald
    Vogelius, Ivan Richter
    Kjaer, Andreas
    Friborg, Jeppe
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (02) : 539 - 547
  • [34] FDG-PET in thyroid cancer
    Crippa, F
    Alessi, A
    Gerali, A
    Bombardieri, E
    TUMORI JOURNAL, 2003, 89 (05): : 540 - 543
  • [35] FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer
    Oku, S
    Nakagawa, K
    Momose, T
    Kumakura, Y
    Abe, A
    Watanabe, T
    Ohtomo, K
    ANNALS OF NUCLEAR MEDICINE, 2002, 16 (06) : 409 - 416
  • [36] FDG-PET and colon cancer
    Ken Miles
    Cancer Imaging, 2003, 3 (2) : 135 - 138
  • [37] FDG-PET and endometrial cancer
    Kolesnikov-Gauthier, Helene
    Carpentier, Philippe
    BULLETIN DU CANCER, 2012, 99 (01) : 21 - 28
  • [38] A systematic review of FDG-PET in breast cancer
    Escalona, S.
    Blasco, J. A.
    Reza, M. M.
    Andradas, E.
    Gomez, N.
    MEDICAL ONCOLOGY, 2010, 27 (01) : 114 - 129
  • [39] Cancer screening with FDG-PET
    Ide, M
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (01) : 23 - 27
  • [40] Imaging Uterine Cervical Cancer with FDG-PET/CT: Direct Comparison with PET
    Tatsumi, Mitsuaki
    Cohade, Christian
    Bristow, Robert E.
    Wahl, Richard L.
    MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (04) : 229 - 235